Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis

被引:0
|
作者
Kamper, EF
Kopeikina, LT
Koutsoukos, V
Stavridis, J
机构
关键词
tetranectin; alpha(2)-antiplasmin; fibrinolysis; rheumatoid arthritis; Stoke index; disease activity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. We investigated alterations of levels of plasma tetranectin, a new regulator of plasminogen activation, in patients with rheumatoid arthritis (RA) in relation to disease activity and Other fibrinolytic variables. Methods. Tetranectin (TN), tissue-type plasminogen activator (t-PA), and plasminogen activator inhibitor (PAI-I) were quantitatively assessed (ELISA) in plasma of 41 patients with RA and 30 healthy subjects. alpha(2)-Antiplasmin activity was assessed by the amidolytic method. Disease activity was determined as a composite Stoke Index, which measures inflammatory processes in RA. Patients were divided into 3 groups according to Stoke Index score of disease activity: A, minimal-mild, 1-7; B, moderate, 8-11; C, severe, 12-17. Results. Plasma TN in patients was significantly lower compared to that of healthy subjects [9.11 (4.97-13.49) mg/l, 12.05 (9.50-13.60) mg/l, median (range), respectively; p = 0.0001]. TN decreases with the increase of disease activity from group to group. A significant negative correlation between TN: and Stoke Index, C-reactive protein and erythrocyte sedimentation rate was found (r(s) -0.49, p = 0.0012; r(s) = -0.44, p = 0.0014; r(s) = -0.37, p = 0.016, respectively). alpha-Antiplasmin activity was elevated in patients compared to healthy subjects [105.0% (53.0-146.0), 70.6% (48.2-124.0), median (range), respectively; p = 0.0001], showing a negative correlation with Stoke Index (r(s) = -0.38, p = 0.0139). The close positive correlation of TN with alpha-antiplasmin (r(s) = 0.66, p = 0.0001) and the absence of correlation with t-PA and PAI-I were explained by the involvement of TN and alpha-antiplasmin in localized rather than in systemic fibrinolysis. Conclusion. Our findings suggest TN plays a role in the pathophysiology of RA and point to the usefulness of TN assessment as a specific fibrinolytic marker in the evaluation of disease activity in patients with RA. The role of TN in the intraarticular regulation of fibrinolysis, important for the expansion of pannus, tissue remodeling and angiogenesis, is discussed.
引用
收藏
页码:262 / 268
页数:7
相关论文
共 50 条
  • [21] Perception of Improvement in Patients With Rheumatoid Arthritis Varies With Disease Activity Levels at Baseline
    Aletaha, D.
    Funovits, J.
    Ward, M. M.
    Smolen, J. S.
    Kvien, T. K.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (03): : 313 - 320
  • [22] The relationship of serum leptin levels with disease activity in Egyptian patients with rheumatoid arthritis
    Allam, Ahmed
    Radwan, Abdullah
    [J]. EGYPTIAN RHEUMATOLOGIST, 2012, 34 (04): : 185 - 190
  • [23] Increased levels of plasma nucleotides in patients with rheumatoid arthritis
    Kishikawa, Toshihiro
    Maeda, Yuichi
    Nii, Takuro
    Arase, Noriko
    Hirata, Jun
    Suzuki, Ken
    Yamamoto, Kenichi
    Masuda, Tatsuo
    Ogawa, Kotaro
    Tsuji, Shigeyoshi
    Matsushita, Masato
    Matsuoka, Hidetoshi
    Yoshimura, Maiko
    Tsunoda, Shinichiro
    Ohshima, Shiro
    Narazaki, Masashi
    Ogata, Atsushi
    Saeki, Yukihiko
    Inohara, Hidenori
    Kumanogoh, Atsushi
    Takeda, Kiyoshi
    Okada, Yukinori
    [J]. INTERNATIONAL IMMUNOLOGY, 2021, 33 (02) : 119 - 124
  • [24] Plasma chemerin as a Useful Marker for Disease Activity in Patients with Rheumatoid Arthritis.
    Choi, Sang Tae
    Ha, You-Jung
    Kang, Eun-Jin
    Lee, Kwang-Hoon
    Song, Jung-Soo
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S897 - S898
  • [25] Alterations of plasma glycosaminoglycan profile in patients with rheumatoid arthritis in relation to disease activity
    Jura-Poltorak, Agnieszka
    Komosinska-Vassev, Katarzyna
    Kotulska, Anna
    Kucharz, Eugeniusz J.
    Klimek, Katarzyna
    Kopec-Medrek, Magdalena
    Olczyk, Krystyna
    [J]. CLINICA CHIMICA ACTA, 2014, 433 : 20 - 27
  • [26] PLASMA + SERUM VISCOSITY AS PARAMETERS OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS (RA) PATIENTS
    SMUKLER, NM
    PATTERSON, JR
    WEINER, L
    LORENZ, H
    [J]. ARTHRITIS AND RHEUMATISM, 1964, 7 (03): : 344 - &
  • [27] Plasma tetranectin levels in patients with unstable and stable angina
    Kopeikina, LT
    Kamper, EF
    Mantas, A
    Kremastinos, D
    Stavridis, JC
    [J]. FIBRINOLYSIS & PROTEOLYSIS, 1998, 12 (06): : 353 - 359
  • [28] The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation
    Hu, Y. L.
    Li, H.
    Li, W. H.
    Meng, H. X.
    Fan, Y. Z.
    Li, W. J.
    Ji, Y. T.
    Zhao, H.
    Zhang, L.
    Jin, X. M.
    Zhang, F. M.
    [J]. LUPUS, 2013, 22 (14) : 1455 - 1461
  • [29] Demonstrating disease activity in patients with rheumatoid arthritis
    Karapolat, I.
    Sertpoyraz, F.
    Oncel, G.
    Kobak, S.
    Yalcin, M.
    Kumanlioglu, K.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2013, 52 (06): : 244 - 249
  • [30] PLASMA NETS LEVELS IN ESTABLISHED RHEUMATOID ARTHRITIS PATIENTS RECEIVING BIOLOGICAL OR JAK INHIBITOR THERAPY AND ASSOCIATION WITH DISEASE ACTIVITY
    Frade-Sosa, B.
    Ponce Fernandez, A.
    Ruiz-Ortiz, E.
    Vinas, O.
    Yague, J.
    Auge, J. M.
    Azuaga, A.
    Sarmiento-Monroy, J. C.
    Morla, R.
    Ruiz, V.
    Ramirez, J.
    Corzo Garcia, P.
    Farietta Varela, S. M.
    Sapena, N.
    Canete, J. D. D.
    Gomez-Puerta, J. A.
    Sanmarti, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1342 - 1343